hemodynamics – Medxy AI

Inhibiting Myeloid-PlexinD1: A Novel Strategy to Stabilize Atherosclerosis at High-Risk Vascular Bifurcations

By MedXY 03/09/2026

Research reveals that PlexinD1 mediates macrophage-driven inflammation in response to disturbed blood flow. By targeting this pathway, scientists have successfully attenuated plaque progression in preclinical models, paving the way for advanced diagnostic imaging and precision therapies in cardiovascular medicine.

Cardiology news

Superior Long-Term Hemodynamics with Self-Expanding Valves in Small Failed Bioprostheses: 3-Year Insights from the LYTEN Trial

By MedXY 03/03/2026

The 3-year analysis of the LYTEN trial reveals that self-expanding valves (SEV) significantly outperform balloon-expandable valves (BEV) in hemodynamic metrics for valve-in-valve TAVR in patients with small surgical bioprostheses, although clinical outcomes and quality of life improvements remain comparable.

Cardiology news

Self-Expanding Valves Outperform Balloon-Expandable Systems in Hemodynamics for Small Valve-in-Valve TAVR: 3-Year LYTEN Trial Results

By MedXY 03/03/2026

The 3-year results of the LYTEN trial demonstrate that self-expanding valves provide significantly better hemodynamic performance than balloon-expandable valves for failed small surgical bioprostheses, although clinical outcomes like mortality and stroke remain comparable between the two systems.

Cardiology Clinical Updates news

The Hemodynamic Paradox of Valve-in-Valve TAVR: Redefining ‘Optimal’ Gradients and Patient-Prosthesis Mismatch

By MedXY 03/02/2026

This review analyzes new registry data revealing that low discharge gradients (<10 mm Hg) after balloon-expandable ViV-TAVR correlate with reduced LVEF and higher 5-year mortality, challenging conventional hemodynamic success metrics.

Cardiology news

Rethinking Hemodynamics in Aortic Stenosis: The Paradoxical Normal-Flow, Low-Ejection Fraction Phenotype and Post-TAVI Outcomes

By MedXY 01/22/2026

A substudy of the COMPARE-TAVI 1 trial identifies a unique NF-LEF phenotype in 10.7% of aortic stenosis patients. Despite reduced LVEF, these patients maintain normal flow through eccentric remodeling and achieve clinical improvements post-TAVI comparable to those with preserved ejection fractions.

Cardiology Critical Care news

Beyond Survival: Unpacking the Hemodynamic and Metabolic Benefits of Microaxial Flow Pumps in STEMI-Related Cardiogenic Shock

By MedXY 12/31/2025

Recent substudies from the DanGer Shock trial demonstrate that microaxial flow pumps significantly improve hemodynamics, accelerate lactate clearance, and reduce vasopressor needs in STEMI-related cardiogenic shock, though sex-specific outcomes are heavily influenced by age and treatment delays.

Cardiology Internal Medicine news

Beyond Congestion: The Wet-Cold Phenotype Drives Mortality in Obese HFpEF

By MedXY 12/29/2025

A hemodynamic study of 227 HFpEF patients reveals that 34% exhibit a low-output phenotype. This cold status, especially when combined with congestion, significantly increases mortality risk in overweight and obese individuals, highlighting the need for precise hemodynamic profiling.

Cardiology Critical Care news Transplantation

The LVAD Paradox in Heart Transplantation: Higher Risk of Primary Graft Dysfunction, Yet Improved Survival Outcomesdszcx

By MedXY 12/29/2025

A large-scale multicenter study reveals that while pre-transplant durable LVAD support increases the incidence of severe primary graft dysfunction (PGD), these patients paradoxically demonstrate significantly better survival rates compared to non-LVAD patients who develop PGD.

Critical Care Internal Medicine news

Higher Blood Pressure Targets in Septic Shock: When More Vasopressors Do More Harm than Good

By MedXY 12/27/2025

A post-hoc analysis of the SEPSIS-PAM trial reveals that while high MAP targets do not provide a universal survival benefit, they significantly increase mortality risk when requiring high norepinephrine doses or failing to resolve microcirculatory dysfunction like skin mottling.

Anesthesiology General Surgery Oncology Specialties

Optimizing Anesthesia in Elderly NSCLC Patients: Impact of Midazolam and Dexmedetomidine Co-Administration on Hemodynamics and Stress Response

By MedXY 09/15/2025

Co-administering midazolam with dexmedetomidine in elderly NSCLC patients undergoing lobectomy enhances hemodynamic stability and reduces perioperative stress response, potentially improving recovery outcomes without increasing adverse events.